You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 4, January 27, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo 1999: Updates Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (21)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Ophthalmology
 •Glaucoma
 •Alert me on articles by topic

New Perspectives on Glaucoma

Evan Benjamin Dreyer, MD, PhD; Stuart A. Lipton, MD, PhD

JAMA. 1999;281:306-308.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Conventional wisdom defines glaucoma as "a collection of ophthalmic disorders in which the intraocular pressure [IOP] is sufficiently elevated to cause excavation and degeneration of the optic disc" (Figure 1).1 The glaucomas are a leading cause of irreversible blindness both worldwide and in the United States.2 Although early physicians could not differentiate between visual loss from glaucoma and cataract, our understanding of glaucoma really dates to 1622. Richard Banister, a British oculist, wrote, "if one feele the eye by rubbing upon the eie-lids that the eye be growne more solid and hard than naturally it should be . . . the humour settled in the hollow nerves be growne to any solid or hard substance, it is not possible to be cured."3 Although his examination retains some currency, we have made some therapeutic progress in the ensuing 377 . . . [Full Text of this Article]

Classic Theories of Glaucomatous Damage

New Explanations for Glaucomatous Damage

A Role for Excitotoxicity in Glaucoma

New Therapeutic Approaches

Author Affiliations: Glaucoma Service, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia (Dr Dreyer), and CNS Research Institute, Brigham and Women's Hospital, and Program in Neuroscience, Harvard Medical School, Boston, Mass (Dr Lipton).


RELATED ARTICLE

January 27, 1999
JAMA. 1999;281(4):391-392.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture
John
IOVS 2005;46:2650-2661.
FULL TEXT  

Neuroprotective Effect of(-){Delta}9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-D-Aspartate-Induced Retinal Neurotoxicity: Involvement of Peroxynitrite
El-Remessy et al.
Am. J. Pathol. 2003;163:1997-2008.
ABSTRACT | FULL TEXT  

Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis
Okamoto et al.
Proc. Natl. Acad. Sci. USA 2002;99:3974-3979.
ABSTRACT | FULL TEXT  

Role of p38 Mitogen-Activated Protein Kinase in Axotomy-Induced Apoptosis of Rat Retinal Ganglion Cells
Kikuchi et al.
J. Neurosci. 2000;20:5037-5044.
ABSTRACT | FULL TEXT  

New Perspectives in Glaucoma
Harris et al.
JAMA 1999;281:2186-2187.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.